24 Oct 2018

Type 2 inflammation rich in eosinophils, basophils and mast cells and orchestrated by Th2 lymphocytes has been mainly studied in the context of allergies and immune responses to helminths. Since the discovery of type 2 innate lymphoid cells there has been a strong interest in understanding how type 2 immunity is induced and regulated, for example by barrier epithelial cells.

Given the recent introduction of new biologics that target type 2 cytokines to treat severe allergic disease, we are accumulating a lot of new insights on type 2 immune responses in humans as well.

The VIB Conference Type 2 Immunity in Homeostasis and Disease will not only focus on new effector and regulatory mechanisms of the type 2 immune response. It will also offer a number of talks taking a broader look on type 2 immunity, dealing with such topics as type 2 immunity in homeostasis, growth and repair, metabolism, neuro-immune interactions and cancer.


Speaker line-up

The program has now been completed. The organizing committee has tried to include some of the key researchers in these fields. 

  • Judi Allen, The University of Manchester, UK
  • David Artis, Weill Cornell Medicine, US
  • Ronald N. Germain, National Institutes of Health, US
  • Elise Dalmas, INSERM, FR
  • Stephen J. Galli, Stanford University, US
  • Ana Domingos, Dept. Physiology, Anatomy, Genetics, University of Oxford, UK
  • Jean-Philippe Girard, CNRS - University of Toulouse, FR
  • Philippe Jay, INSERM, FR
  • Kazuyo Moro, Laboratory for Innate Immune systems, RIKEN IMS, JP
  • Andrew McKenzie, MRC Laboratory of Molecular Biology, UK
  • Anna Molofsky, University of California-San Francisco, US
  • Ariel Munitz, Sackler School of Medicine, Tel Aviv University, IL
  • Marion Pepper, Department of Immunology, University of Washington, US
  • Wayne Shreffler, Massachusetts General Hospital, US
  • Henrique Veiga-Fernandes, Champalimaud Centre for the Unknown, PT
  • Steve F. Ziegler, Benaroya Research Institute, US
  • Bart Lambrecht, VIB-UGent Center for Inflammation Research, BE
  • Richard Locksley, Department of Medicine, University of California San Francisco, US


Call for Abstracts

We encourage young scientists to present their own research to the international community during one of our poster sessions. The best abstracts will be selected for a short oral presentation.

Abstracts can be submitted for the following topics:

  • Tissue homeostasis and repair
  • Type 2 Neuro-immune axis
  • Type 2 in allergy, asthma & helminth infection
  • Type 2 Immunity & Cancer

The abstract submission deadline is 15 December 2018. Submit yours on the conference website

Related conferences